Kazi Md. Faisal Hoque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazi Md. Faisal Hoque has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Abu Reza
Molecular Biology and Protein Science Laboratory, Department of Genetic Engineering & Biotechnology, University of Rajshahi, Rajshahi-6205, Bangladesh
2 shared publications- Mohammad Shahangir Biswas
Department of Biochemistry and Biotechnology University of Science & Technology Chittagong (USTC) Chittagong Bangladesh
2 shared publications - Abu Reza
University of Rajshahi
1 shared publication - Ajmeri Sultana Shimu
Department of Medical Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
1 shared publication Amaal E. Ahmed
Department of Pathology, Faculty of Veterinary Medicine, Aswan University, Egypt
1 shared publication- Anil Chandra Deb
Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 10 March 2026
- Published by MIT Press in Harvard Data Science Review
- Vol. 8 (3)
From Knowledge to Value: Rethinking Knowledge Management Principles for an AI-Powered World
- 10 March 2026
- Published by MIT Press in Harvard Data Science Review
- Vol. 8 (3)
Open AccessFrom Knowledge to Value: Rethinking Knowledge Management Principles for an AI-Powered World
- Open Access
- 20 February 2026
- Published by Elsevier in SSRN Electronic Journal
Inhibitory efficacy and binding mode prediction of natural compounds against pathogenic factors of Alternaria solani: insights from AlphaFold, molecular simulations, and post-simulation analyses
Early blight disease, caused by the fungal pathogen Alternaria solani, is a significant threat to global crop production, particularly affecting widely cultivated crops such as potatoes and tomatoes. The emergence of fungicide resistance and growing environmental concerns have intensified the need for sustainable alternatives to conventional chemical fungicides. This study explores the potential of natural agents to combat A. solani by targeting two key effector proteins, AsCEP112 and AsCEP50, which play critical roles in the infection process. A comprehensive library of 608 natural compounds with known antifungal properties was evaluated using advanced computational approaches. Molecular docking simulation studies identified BR-xanthone A as a highly potent compound, demonstrating superior binding affinities to both the target proteins compared to reference fungicides (Strobilurin and Azoxystrobin). Additionally, Allicin with AsCEP50 and Alpha-mangostin with AsCEP112 exhibited promising binding energies. High-throughput molecular dynamics (MD) simulations assessed stability and interactions, with parameters such as RMSD, RMSF, Rg, SASA, and hydrogen bonds. Post-simulation analyses, including MM-PBSA, PCA, FEL, and PDF, further validated the stability nature of the ligand-protein complexes and revealed probable conformational changes. BR-xanthone A also displayed excellent bioactivity scores and fungicide-likeness, outperforming the reference compounds. This study highlights the potential of natural fungicides as sustainable and effective alternatives to traditional chemical treatments. The selected compound, BR-xanthone A, emerged as a strong candidate for developing next-generation fungicides by specifically targeting fungal virulence factors. The findings provide valuable insights for developing future eco-friendly fungus control agents and enhancing global food security in the face of fungal pathogen threats.
- 20 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInhibitory efficacy and binding mode prediction of natural compounds against pathogenic factors of Alternaria solani: insights from AlphaFold, molecular simulations, and post-simulation analyses
Early blight disease, caused by the fungal pathogen Alternaria solani, is a significant threat to global crop production, particularly affecting widely cultivated crops such as potatoes and tomatoes. The emergence of fungicide resistance and growing environmental concerns have intensified the need for sustainable alternatives to conventional chemical fungicides. This study explores the potential of natural agents to combat A. solani by targeting two key effector proteins, AsCEP112 and AsCEP50, which play critical roles in the infection process. A comprehensive library of 608 natural compounds with known antifungal properties was evaluated using advanced computational approaches. Molecular docking simulation studies identified BR-xanthone A as a highly potent compound, demonstrating superior binding affinities to both the target proteins compared to reference fungicides (Strobilurin and Azoxystrobin). Additionally, Allicin with AsCEP50 and Alpha-mangostin with AsCEP112 exhibited promising binding energies. High-throughput molecular dynamics (MD) simulations assessed stability and interactions, with parameters such as RMSD, RMSF, Rg, SASA, and hydrogen bonds. Post-simulation analyses, including MM-PBSA, PCA, FEL, and PDF, further validated the stability nature of the ligand-protein complexes and revealed probable conformational changes. BR-xanthone A also displayed excellent bioactivity scores and fungicide-likeness, outperforming the reference compounds. This study highlights the potential of natural fungicides as sustainable and effective alternatives to traditional chemical treatments. The selected compound, BR-xanthone A, emerged as a strong candidate for developing next-generation fungicides by specifically targeting fungal virulence factors. The findings provide valuable insights for developing future eco-friendly fungus control agents and enhancing global food security in the face of fungal pathogen threats.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Biochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Open AccessBiochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.
- Open Access
- 26 August 2021
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 29 (1) , 211-216
Bioremediation potential of hydrocarbon degrading bacteria: isolation, characterization, and assessment
- 26 August 2021
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 29 (1) , 211-216
Open AccessBioremediation potential of hydrocarbon degrading bacteria: isolation, characterization, and assessment
- Open Access
- 1 March 2021
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 28 (3) , 2014-2022
A comparative study of biological potentiality and EAC cell growth inhibition activity of Phyllanthus acidus (L.) fruit pulp and seed in Bangladesh
- 1 March 2021
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 28 (3) , 2014-2022
Open AccessA comparative study of biological potentiality and EAC cell growth inhibition activity of Phyllanthus acidus (L.) fruit pulp and seed in Bangladesh